Cargando…
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
There is the need for a clinical assay to determine the extent to which a patient's blood is effectively anticoagulated by the low-molecular-weight-heparin (LMWH), enoxaparin. There are also urgent clinical situations where it would be important if this could be determined rapidly. The present...
Autores principales: | Inchiosa, Mario A., Pothula, Suryanarayana, Kubal, Keshar, Sanchala, Vajubhai T., Navarro, Iris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490316/ https://www.ncbi.nlm.nih.gov/pubmed/23093300 http://dx.doi.org/10.3791/3852 |
Ejemplares similares
-
Anesthesiologists' Preferences regarding Visitor Presence during Placement of Neuraxial Labor Analgesia
por: Kumaraswami, Sangeeta, et al.
Publicado: (2018) -
Neural Network Prediction of ICU Length of Stay Following Cardiac Surgery Based on Pre-Incision Variables
por: LaFaro, Rocco J., et al.
Publicado: (2015) -
Subcutaneous Enoxaparin for Systemic Anticoagulation of COVID-19 Patients During Extracorporeal Life Support
por: Wiegele, Marion, et al.
Publicado: (2022) -
Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008) -
Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)